Clinical trial
One Year Study to Evaluate the Safety of the Combination of Valsartan and…
NCT00409851 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00409851 |
|---|---|
| Title | One Year Study to Evaluate the Safety of the Combination of Valsartan and Amlodipine in Patients With Hypertension |
| Official title | A 52 Week, Open Label Extension to the Randomized, Double-blind, Multicenter, Multifactorial, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients. |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | valsartan+amlodipine |
| Enrollment | 1,293 |
| Start date | Apr 1, 2003 |
| Primary completion | Mar 1, 2005 |
| Completion | Mar 1, 2005 |
| First posted | Dec 11, 2006 |
| Last update posted | Nov 8, 2011 |
| Countries | Germany, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: